Refractive Surgery Devices Market Size, Share & Forecast Analysis to 2030

The global refractive surgery devices market size was valued at around USD 0.3 billion in 2025 and expected to grow at a significant CAGR of over 9% during the forecast period from 2026 to 2030. The market is witnessing steady growth due to the rising prevalence of myopia, hyperopia, and other vision disorders worldwide. Increasing adoption of advanced laser-based procedures such as LASIK and SMILE, along with continuous innovations in ophthalmic surgical technologies, is driving market expansion. North America currently leads the market, while Asia Pacific is expected to register significant growth during the forecast period.

Market Sapshot:

Key Findings:

• The global refractive surgery devices market is growing due to rising cases of myopia, hyperopia, astigmatism, and other vision disorders worldwide.
• The lasers segment dominates the market, supported by widespread adoption of excimer and femtosecond laser technologies in advanced vision correction procedures.
• The myopia segment holds the leading position among applications due to the increasing global prevalence of nearsightedness and growing demand for laser vision correction treatments.
• North America leads the market due to advanced healthcare infrastructure, high procedure adoption, and strong presence of ophthalmic device manufacturers.

Key Factors Driving the Refractive Surgery Devices Market Growth

The increasing prevalence of refractive errors such as myopia, hyperopia, and astigmatism is a key factor driving the growth of the refractive surgery devices market. Rising screen exposure, changing lifestyles, and growing preference for spectacle-free vision correction are encouraging patients to adopt advanced procedures, including LASIK, PRK, and SMILE. In addition, continuous improvements in femtosecond lasers, excimer lasers, and corneal imaging technologies are enhancing surgical accuracy, reducing recovery time, and improving overall patient outcomes, supporting the adoption of advanced refractive surgery devices.

Technological innovation and increasing investments in ophthalmic care infrastructure are further strengthening market growth. In March 2025, the U.S. Food and Drug Administration (FDA) updated its list of approved lasers for LASIK procedures, including advanced excimer laser systems used for customized vision correction, reflecting continued development in laser-based refractive surgery technologies. The growing adoption of advanced laser platforms, along with rising demand for minimally invasive vision correction procedures, is expected to create new opportunities for refractive surgery device manufacturers during the forecast period.

Key Growth Drivers:

• Rising prevalence of myopia and other refractive errors is increasing demand for advanced vision correction procedures globally.
• Technological advancements in laser systems are improving refractive surgery accuracy, safety, and patient recovery outcomes.
• Growing preference for minimally invasive procedures like LASIK and SMILE is accelerating adoption of refractive surgery devices.

Refractive Surgery Devices Market Restraints

The high cost associated with refractive surgery procedures and advanced surgical devices is a major factor limiting market growth, particularly in developing regions. Many patients avoid elective vision correction procedures due to affordability concerns, as these treatments are often not covered by insurance plans. Additionally, the requirement for skilled ophthalmic surgeons and specialized infrastructure increases the overall cost of adopting advanced refractive surgery technologies.

Concerns regarding potential surgical complications, including dry eyes, visual disturbances, and regression of vision correction, may also restrict patient acceptance of refractive procedures. Furthermore, limited awareness about advanced refractive surgery options in emerging markets and strict regulatory requirements for medical device approvals can delay product adoption and expansion opportunities for manufacturers.

Growth opportunities in the Global Refractive Surgery Devices Market

The increasing adoption of advanced vision correction procedures in emerging economies presents significant growth opportunities for refractive surgery device manufacturers. Rising healthcare investments, expanding ophthalmic clinics, and improving access to specialized eye care services across Asia Pacific and Latin America are supporting market expansion. Additionally, growing awareness about spectacle-free vision correction and increasing demand for personalized treatments are encouraging the adoption of advanced laser-based refractive surgery systems.

The development of next-generation ophthalmic technologies, including advanced laser platforms, improved imaging systems, and AI-assisted surgical solutions, is expected to create new opportunities in the refractive surgery devices market. In April 2025, Alcon announced the launch of its UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS), featuring technologies such as UNITY 4D Phaco, HYPERVIT 30K, and UNITY Intelligent Fluidics designed to enhance surgical efficiency and precision in ophthalmic procedures. These innovations highlight the growing focus on improving surgical outcomes and workflow efficiency, which is expected to encourage further advancements and investments in ophthalmic surgical device technologies.

Key Growth Opportunities:

• Rising adoption of refractive surgery procedures in emerging markets is creating opportunities through expanding ophthalmic infrastructure and healthcare access.
• Development of AI-based diagnostics and customized laser technologies is enabling personalized treatments and improving surgical outcomes.
• Increasing investments by leading ophthalmic device companies in advanced surgical platforms are driving innovation and market expansion opportunities.

Industry Trends Shaping the Global Refractive Surgery Devices Market

The increasing adoption of advanced laser vision correction technologies is a major trend shaping the refractive surgery devices market. Ophthalmic providers are increasingly utilizing femtosecond lasers, wavefront-guided systems, and advanced corneal mapping technologies to deliver more precise and customized treatments. The growing popularity of minimally invasive procedures, including SMILE, is also supporting market growth as patients seek faster recovery, reduced discomfort, and improved visual outcomes compared with traditional correction methods.

The integration of personalized treatment planning and next-generation laser platforms is further transforming the refractive surgery landscape. In January 2025, Carl Zeiss Meditec received U.S. FDA approval for its ZEISS MEL 90 excimer laser, expanding its laser vision correction portfolio for treating myopia, hyperopia, and mixed astigmatism. The system integrates with the ZEISS Corneal Refractive Workflow to support efficient and streamlined refractive procedures. These advancements highlight the industry’s shift toward customized, data-driven refractive surgery solutions that improve treatment precision, workflow efficiency, and patient outcomes.

Market Segments Insights:

By Device Type, the Laser Segment Dominated the Global Refractive Surgery Devices Market

On the basis of device type, the lasers segment dominates the refractive surgery devices market due to its widespread application in LASIK, PRK, and other advanced vision correction procedures. Excimer and femtosecond lasers provide high accuracy, improved safety, and customized treatment capabilities, making them the preferred technologies among ophthalmic surgeons. The increasing prevalence of refractive errors, rising demand for spectacle-free vision correction, and growing adoption of minimally invasive procedures are driving the demand for advanced laser-based systems.

Continuous innovation in femtosecond laser platforms, improved treatment workflows, and enhanced surgical precision are further strengthening the dominance of this segment. In August 2023, Johnson & Johnson Vision announced the launch of the ELITA™ Platform at the European Society of Cataract and Refractive Surgeons (ESCRS) Congress, introducing the next-generation ELITA Femtosecond Laser with the new SILK (Smooth Incision Lenticule Keratomileusis) procedure for correcting myopia with or without astigmatism. The platform uses an ultra-precise laser pulse and fast laser delivery system to support smooth lenticule removal and next-day recovery outcomes. This innovation highlights the continued shift toward advanced femtosecond laser technologies and is expected to support the leading position of the lasers segment in the refractive surgery devices market.

By Application, the Myopia Sub-category Holds the Largest Share of Global Refractive Surgery Devices Market

On the basis of application, the myopia segment dominates the refractive surgery devices market due to the rapidly increasing prevalence of nearsightedness across both developed and developing countries. Rising digital screen usage, urbanization, reduced outdoor activities, and changing lifestyles have significantly increased the number of individuals seeking permanent vision correction. As a result, procedures such as LASIK, SMILE, and PRK continue to witness higher adoption, driving demand for advanced refractive surgery devices.

The expanding global burden of myopia is expected to sustain the segment’s dominance throughout the forecast period. According to the World Health Organization (WHO), the number of people with myopia is projected to reach approximately 3.36 billion by 2030, driven largely by modifiable lifestyle-related risk factors such as increased near-work activities and reduced time spent outdoors. This growing patient population is expected to accelerate the adoption of laser vision correction procedures and strengthen demand for advanced refractive surgery devices worldwide.

Global Refractive Surgery Devices Market Segmentation:

By Type:

• Lasers
• Microkeratomes
• Aberrometers
• Flap Creation Systems
• Others

By Surgery Type:

• LASIK (Laser-Assisted In Situ Keratomileusis)
• Photorefractive Keratectomy (PRK)
• SMILE (Small Incision Lenticule Extraction)
• Conductive Keratoplasty
• Others

By Application:

• Myopia
• Hyperopia
• Astigmatism
• Presbyopia
• Others

By End User:

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgery Centers (ASCs)

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: North America Holds the Largest Revenue Share of the Global Refractive Surgery Devices Market

Geographically, the North America dominates the refractive surgery devices market due to its advanced healthcare infrastructure, high adoption of laser vision correction procedures, and strong presence of leading ophthalmic device manufacturers. The region benefits from a large number of specialized eye care centers, favorable regulatory support, and increasing patient awareness regarding permanent vision correction. Continuous investments in innovative surgical technologies and skilled ophthalmic professionals further strengthen the region’s market leadership.

The region also maintains its leading position through the rapid commercialization of next-generation refractive surgery technologies. In January 2024, the U.S. Food and Drug Administration (FDA) approved the ZEISS VISUMAX® 800 with SMILE® pro software for the surgical treatment of myopia with or without astigmatism. The system offers faster treatment, greater surgical flexibility, and enhanced clinical workflow, expanding access to advanced refractive surgery technology across the United States.

Competitive Analysis:

The refractive surgery devices market is moderately consolidated, with leading companies competing through technological innovation, product portfolio expansion, regulatory approvals, and strategic collaborations. Major players are investing heavily in next-generation femtosecond and excimer laser systems, AI-enabled surgical planning, and advanced diagnostic technologies to improve surgical precision and patient outcomes. Companies are also expanding their geographic presence by strengthening distribution networks and increasing partnerships with hospitals and specialized ophthalmic clinics.

Key market participants, including Alcon Inc., Johnson & Johnson Vision, Carl Zeiss Meditec AG, Bausch + Lomb Corporation, and Ziemer Ophthalmic Systems AG, are focusing on continuous product innovation and expanding clinical adoption of advanced refractive surgery platforms. Their competitive strategies emphasize enhancing workflow efficiency, improving treatment customization, and supporting surgeon training programs to strengthen their market position and address the growing global demand for laser vision correction procedures.

Key Companies:

• Alcon Inc.
• Johnson & Johnson Vision
• Carl Zeiss Meditec AG
• Bausch + Lomb Corporation
• Ziemer Ophthalmic Systems AG
• SCHWIND eye-tech-solutions GmbH
• NIDEK Co., Ltd.
• Lumenis Ltd.
• Topcon Corporation
• STAAR Surgical Company

Global Refractive Surgery Devices Market Outlook

• Increasing prevalence of myopia and other refractive disorders will continue driving demand for advanced vision correction procedures globally.
• Continuous advancements in femtosecond lasers, excimer lasers, and AI-enabled surgical planning will enhance treatment precision and efficiency.
• Growing adoption of minimally invasive procedures such as LASIK and SMILE will create significant growth opportunities for market participants.
• Rising healthcare investments and expanding ophthalmic care infrastructure in emerging economies will accelerate market expansion during the forecast period.
• Strategic product innovations, regulatory approvals, and collaborations among leading manufacturers will strengthen competition and support long-term market growth.

Frequently Asked Questions about the Refractive Surgery Devices Market